Citadel Advisors’s BioNexus Gene Lab BGLC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,877
| Closed | -$23.3K | – | 5877 |
|
|
2025
Q1 | $23.3K | Buy |
+9,877
| New | +$23.3K | ﹤0.01% | 5557 |
|
|
2024
Q1 | – | Sell |
-3,359
| Closed | -$18.1K | – | 6124 |
|
|
2023
Q4 | $18.1K | Sell |
3,359
-1,816
| -35% | -$9.79K | ﹤0.01% | 5397 |
|
|
2023
Q3 | $43.5K | Buy |
+5,175
| New | +$43.5K | ﹤0.01% | 5118 |
|